Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banglun Pan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Health Science Reports|November 18, 2020
A prognostic risk model based on immune-related genes predicts overall survival of patients with hepatocellular carcinomaBanglun Pan, Lin Liu, Wei Li
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 22, 2021
Increased effects of 2,5-dimethylcelecoxib on sensitivity of hepatocellular carcinoma cells to sorafenib via CYP3A5 expression and activation of AMPKYiyin Chen, Banglun Pan, Jiacheng Qiu, et al.
Toxicology|April 22, 2021
Interleukin 33 mediates hepatocyte autophagy and innate immune response in the early phase of acetaminophen-induced acute liver injuryZengbin Wang, Linqing Wu, Banglun Pan, et al.
Cell Biology and Toxicology|April 19, 2022
Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expressionLirong Peng, Banglun Pan, Xiaoxia Zhang, et al.
International Journal of Experimental Pathology|April 16, 2022
lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune responseXiaoxia Zhang, Banglun Pan, Jiacheng Qiu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 15, 2023
XPO1 intensifies sorafenib resistance by stabilizing acetylation of NPM1 and enhancing epithelial-mesenchymal transition in hepatocellular carcinomaZengbin Wang, Banglun Pan, Yuxin Yao, et al.
Nature Communications|February 3, 2026
Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular trapsBanglun Pan, Yuxin Yao, Zhu Zhang, et al.
Archives of Pharmacal Research|November 24, 2025
Inhibition of RBPJ transcription complex promotes IL-17 and IFN-γ secretion by CD4⁺ T cells in hepatocellular carcinomaYuxin Yao, Xinyu Zhang, Hao Wu, et al.
Gene|December 25, 2022
Prognostic and immunotherapeutic predictive value of interleukin enhancer-binding factor 3 in hepatocellular carcinoma: Integrated bioinformatics and experimental analysisJiacheng Qiu, Xiaoxuan Wu, Yue Luo, et al.
Cell Communication and Signaling : CCS|April 20, 2023
IL-33/ST2 antagonizes STING signal transduction via autophagy in response to acetaminophen-mediated toxicological immunityZengbin Wang, Pei Sun, Banglun Pan, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Health Science Reports|November 18, 2020
A prognostic risk model based on immune-related genes predicts overall survival of patients with hepatocellular carcinomaBanglun Pan, Lin Liu, Wei Li
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 22, 2021
Increased effects of 2,5-dimethylcelecoxib on sensitivity of hepatocellular carcinoma cells to sorafenib via CYP3A5 expression and activation of AMPKYiyin Chen, Banglun Pan, Jiacheng Qiu, et al.
Toxicology|April 22, 2021
Interleukin 33 mediates hepatocyte autophagy and innate immune response in the early phase of acetaminophen-induced acute liver injuryZengbin Wang, Linqing Wu, Banglun Pan, et al.
Cell Biology and Toxicology|April 19, 2022
Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expressionLirong Peng, Banglun Pan, Xiaoxia Zhang, et al.
International Journal of Experimental Pathology|April 16, 2022
lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune responseXiaoxia Zhang, Banglun Pan, Jiacheng Qiu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 15, 2023
XPO1 intensifies sorafenib resistance by stabilizing acetylation of NPM1 and enhancing epithelial-mesenchymal transition in hepatocellular carcinomaZengbin Wang, Banglun Pan, Yuxin Yao, et al.
Nature Communications|February 3, 2026
Escherichia coli promotes colorectal cancer metastasis by maintaining enhancer-promoter loops through releasing neutrophil extracellular trapsBanglun Pan, Yuxin Yao, Zhu Zhang, et al.
Archives of Pharmacal Research|November 24, 2025
Inhibition of RBPJ transcription complex promotes IL-17 and IFN-γ secretion by CD4⁺ T cells in hepatocellular carcinomaYuxin Yao, Xinyu Zhang, Hao Wu, et al.
Gene|December 25, 2022
Prognostic and immunotherapeutic predictive value of interleukin enhancer-binding factor 3 in hepatocellular carcinoma: Integrated bioinformatics and experimental analysisJiacheng Qiu, Xiaoxuan Wu, Yue Luo, et al.
Cell Communication and Signaling : CCS|April 20, 2023
IL-33/ST2 antagonizes STING signal transduction via autophagy in response to acetaminophen-mediated toxicological immunityZengbin Wang, Pei Sun, Banglun Pan, et al.
Pageof 3